Key facts
- Omedus’s last known valuation is $25.0M (Jan 2026).
- It has raised $1.5M; the latest was Early Stage VC ($5.0M) in Jan 2026.
- Notable investors include Innosphere Ventures, Nebraska Innovation Fund: Prototype Fund (Grant).
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Omedus
- ·The full record, as it builds
Funding rounds
No funding rounds for Omedus are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Omedus
Developer of an autonomous hardware and software platform designed to automate triage for first responders in and out of hospital settings. The company offers integrated triage hardware, real-time patient assessment software, and automated data capture tools, enabling emergency medical personnel and hospital care teams to improve response accuracy and patient prioritization.
- Sector
- Healthcare
- HQ
- Omaha, NE, United States
- Founded
- 2024
- Employees
- 4
- Website
- triage360.com/
- Ownership
- Privately Held (backing)
Omedus doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Omedus shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Omedus in its N-PORT filings yet. We sweep new filings monthly.